Bausch Health Companies (BHC) Change in Taxes (2009 - 2012)
Bausch Health Companies (BHC) reported Change in Taxes of $34.6 million for Q4 2012, up 1994.57% on a YoY basis from $1.6 million in Q1 2012, and up 11211.58% sequentially from -$311000.0 in Q3 2012.
Bausch Health Companies (BHC) Change in Taxes (2009 - 2012) Analysis & Trends
Bausch Health Companies (BHC) has 4 years of Change in Taxes data on file, last reported at $34.6 million in Q4 2012.
- For the quarter ending Q4 2012, Change in Taxes rose 1994.57% year-over-year to $34.6 million; the trailing twelve-month figure through Dec 2012 stood at $20.7 million (up 233.57% YoY), and the FY2012 full-year result was $20.7 million, up 233.57% from the prior year.
- Change in Taxes improved to $34.6 million in Q4 2012, from -$311000.0 in the prior quarter.
- In the past five years, Change in Taxes ranged from a high of $34.6 million in Q4 2012 to a low of -$15.1 million in Q2 2012.
- A 4-year average of -$320266.7 and a median of -$320000.0 in 2009 frame the typical range for Change in Taxes.
- Across the five-year window, Change in Taxes sank 1296.59% in 2010 and surged 1994.57% in 2012, its largest moves.
- Tracing BHC's Change in Taxes over 4 years: stood at -$850000.0 in 2009, then slumped by 1296.59% to -$11.9 million in 2010, then soared by 84.63% to -$1.8 million in 2011, then surged by 1994.57% to $34.6 million in 2012.
- Business Quant data shows BHC's Change in Taxes at $34.6 million in Q4 2012, -$311000.0 in Q3 2012, and -$15.1 million in Q2 2012.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 73.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -411.14 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -463.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 119.80 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Bausch Health Companies | 1.66 Bn | 1.33 Bn | 2.52 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2012 | 34.56 Mn |
| Dec 31, 2012 | 34.56 Mn |
| Sep 30, 2012 | -311,000.00 |
| Sep 30, 2012 | -311,000.00 |
| Jun 30, 2012 | -15.12 Mn |
| Jun 30, 2012 | -15.12 Mn |
| Mar 31, 2012 | 1.58 Mn |
| Mar 31, 2012 | 1.58 Mn |
| Dec 31, 2011 | -1.82 Mn |
| Dec 31, 2011 | -1.82 Mn |
| Sep 30, 2011 | 920,000.00 |
| Sep 30, 2011 | 920,000.00 |
| Jun 30, 2011 | -13.73 Mn |
| Jun 30, 2011 | -13.73 Mn |
| Mar 31, 2011 | -863,000.00 |
| Mar 31, 2011 | -863,000.00 |
| Dec 31, 2010 | -11.87 Mn |
| Dec 31, 2010 | -11.87 Mn |
| Sep 30, 2010 | -2.93 Mn |
| Sep 30, 2010 | -2.93 Mn |